"
Worldwide, there are plants known as psychoactive plants that naturally contain psychedelic active components. They have a high concentration of neuroprotective substances that can interact with the nervous system to produce psychedelic effects. Despite these plants' hazardous potential, recreational use of them is on the rise because of their psychoactive properties. Early neuroscience studies relied heavily on psychoactive plants and plant natural products (NPs), and both recreational and hazardous NPs have contributed significantly to the understanding of almost all neurotransmitter systems. Worldwide, there are many plants that contain psychoactive properties, and people have been using them for ages. Psychoactive plant compounds may significantly alter how people perceive the world.
CAS ID |
N/A |
||
INCHI KEY |
STECJAGHUSJQJN-USLFZFAMSA-N |
||
MOLECULAR WEIGHT |
303.35 |
||
MOLECULAR FORMULA |
C17H21NO4 |
||
MOLECULAR MASS |
303.358 |
||
BIOLOGICAL SOURCE |
Brugmansia suaveolens |
||
DATA SOURCE |
Vivek-Ananth, R. P., Mohanraj, K., Sahoo, A. K., & Samal, A. (2023). IMPPAT 2.0: An Enhanced and Expanded Phytochemical Atlas of Indian Medicinal Plants. ACS omega, 8(9), 8827–8845. https://doi.org/10.1021/acsomega.3c00156 | ||
CHEMICAL CLASS OF COMPOUND |
Hydroxy acids and derivatives |
||
NLRP3 DOCKING SCORE(Kcal/mol) |
-6.134 |
||
CANONICAL SMILES CN1[C@@H]2CC(OC(=O)[C@H](CO)c3ccccc3)C[C@H]1[C@@H]1O[C@@H]12
|
|||
BIOACTIVITY REPORTED FOR NEURODEGENERATIVE DISEASES
Yes
|
|||
SYNONYMS |
scopolamine, Hyoscine, (-)-Hyoscine, 51-34-3, Scopine (-)-tropate, Scopine tropate, (-)-Scopolamine, Hyosol, 6,7-Epoxytropine tropate, Transderm-Scop, Atrochin, Atroquin, Isopto Hyoscine, Skopolamin, l-Scopolamine, Epoxytropine tropate, Scopolamine hydrobromide, 6-beta,7-beta-Epoxy-3-alpha-tropanyl S-(-)-tropate, Beldavrin, Scopamin, Kwells, alpha-(Hydroxymethyl)benzeneacetic acid 9-methyl-3-oxa-9-azatricyclo(3.3.1.0(2.4))non-7-yl ester, Hyosceine, Transcop, Scop, DL48G20X8X, Tropic acid, ester with scopine, CHEMBL3084722, CHEBI:16794, Euscopol, Isoscopil, Tranaxine, (1S,3S,5R,6R,7S)-6,7-epoxytropan-3-yl (2S)-3-hydroxy-2-phenylpropanoate, Hysco, Hyoscine bromide, Scopace, Transderm scop, Scopolamine HCl, Boro-Scopol, Hyoscine hydrobromide, Scopolaminium bromide, 1alphaH,5alphaH-Tropan-3alpha-ol, 6beta,7beta-epoxy-, (-)-tropate (ester), Scopolammonium bromide, l-Hyoscine hydrobromide, SEE, (-)-Scopolamine bromide, l-Scopolamine-hydrobromide, SCOPOLAMINE BROMIDE, (-)-Hyoscine hydrobromide, Scopoderm, levo-duboisine, (+)-Hyoscine, (1R,2R,4S,5S,7S)-9-methyl-3-oxa-9-azatricyclo[3.3.1.0(2,4)]non-7-yl (2S)-3-hydroxy-2-phenylpropanoate, (1R,2R,4S,5S,7s)-9-Methyl-3-oxa-9-azatricyclo[3.3.1.0~2,4~]nonan-7-yl (2S)-3-hydroxy-2-phenylpropanoate, Hyoscyine hydrobromide, Hydroscine hydrobromide, hydrobromicum, Scopolaminum, UNII-DL48G20X8X, Tropane alkaloid, HSDB 4074, 6.beta.,7.beta.-Epoxy-1.alpha.H,5.alpha.H-tropan-3.alpha.-ol (-)-tropate (ester), EINECS 200-090-3, NSC61806, S-(-)-Tropate, SCOPOLAMINE [MI], Prestwick3_000877, HYOSCINE [MART.], SCOPOLAMINE [HSDB], HYOSCINE [WHO-DD], EC 200-090-3, SCOPOLAMINE [VANDF], (-)-Scopolamin (Hyoscine), 6beta,7beta-Epoxy-3alpha-tropanyl S-(-)-tropate, SCHEMBL16226, BSPBio_000953, GTPL330, 6beta,7beta-Epoxy-1alpha,5alpha-tropan-3alpha-ol, HYOSCINE [EP IMPURITY], BPBio1_001049, CHEMBL569713, HYOSCINE [EP MONOGRAPH], CHEMBL1906925, DTXSID6023573, SCHEMBL22393238, CHEBI:93572, SCOPOLAMINE [ORANGE BOOK], STECJAGHUSJQJN-FWXGHANASA-N, HMS2090N13, HMS3886L22, SCOPOLAMINE [USP IMPURITY], (1R,2R,4S,5S,7s)-9-methyl-3-oxa-9-azatricyclo[3.3.1.02,4]nonan-7-yl (S)-3-hydroxy-2-phenylpropanoate, HY-N0296, LSM-4015, AC-968, BDBM50263508, s9326, AKOS025402477, Scopolamine dried down 100 microg/mL, Tropic acid, 9-methyl-3-oxa-9-azatricyclo(3.3.1.0(sup 2,4))non-7-yl ester, CCG-267504, CS-6609, DB00747, 3-Oxa-9-azatricyclo(3.3.1.0(sup 2,4))nonan-7-ol, 9-methyl-, tropate (ester), 3-Oxa-9-azatricyclo(3.3.1.O(sup 2,4))nonan-7-ol, 9-methyl-, tropate (ester), SMP1_000270, NCGC00024357-04, NCGC00024357-05, 1ST10286, DA-67494, Scopolamine 100 microg/mL in Acetonitrile, AB00429689, AB00429689-30, AB00429689-31, AB00429689_32, EN300-1718536, ATROPINE SULFATE IMPURITY F [EP IMPURITY], Q337188, (methyl[?]yl) (2S)-3-hydroxy-2-phenyl-propanoate, BRD-K89923877-003-02-4, BRD-K89923877-004-15-4, BRD-K89923877-004-16-2, Q27165268, (1R,2R,4S,5S,7R)-9-methyl-3-oxa-9-azatricyclo[3.3.1.0,2,4]nonan-7-yl (2S)-3-hydroxy-2-phenylpropanoate, (1R,2R,4S,5S,7R)-9-methyl-3-oxa-9-azatricyclo[3.3.1.0,nonan-7-yl (2S)-3-hydroxy-2-phenylpropanoate, (1R,2R,4S,5S,7S)-9-METHYL-3-OXA-9-AZATRICYCLO(3.3.1.02,4)NON-7-YL (2S)-3-HYDROXY-2-PHENYLPROPANOATE, (1R,2R,4S,5S,7S)-9-methyl-3-oxa-9-azatricyclo[3.3.1.0^{2,4}]nonan-7-yl (2S)-3-hydroxy-2-phenylpropanoate, (1R,2R,4S,5S,7S)-9-methyl-3-oxa-9-azatricyclo[3.3.1.0~2,4~]non-7-yl (2S)-3-hydroxy-2-phenylpropanoate, (1R,2R,4S,5S,7S)-9-methyl-3-oxa-9-azatricyclo[3.3.1.02,4]non-7-yl (2R)-3-hydroxy-2-phenylpropanoate, (1R,2R,4S,5S,7s)-9-methyl-3-oxa-9-azatricyclo[3.3.1.02,4]nonan-7-yl (2S)-3-hydroxy-2-phenylpropanoate, [(1R,2R,4S,5S)-9-methyl-3-oxa-9-azatricyclo[3.3.1.02,4]nonan-7-yl] (2S)-3-hydroxy-2-phenylpropanoate, [7(S)-(1.alpha.,2.beta.,4.beta.,5.alpha.,7.beta.)]-.alpha.-(Hydroxymethyl)benzeneacetic acid 9-methyl-3-oxa-9-azatricyclo-[3.3.1.0^2,4]non-7-yl ester, BENZENEACETIC ACID, .ALPHA.(HYDROXYMETHYL)-,(1.ALPHA.,2.BETA.,4.BETA.,5.ALPHA.,7.BETA.)-9-METHYL-3-OXA-9-AZATRICYCLO(3.3.1.02,4)NON-7-YL ESTER, (.ALPHA.S)-, BENZENEACETIC ACID, .ALPHA.-(HYDROXYMETHYL)-, 9-METHYL-3-OXA-9-AZATRICYCLO(3.3.1.02,4)NON-7-YL ESTER, (7(S)-(1.ALPHA.,2.BETA.,4.BETA.,5.ALPHA.,7.BETA.))-, Benzeneacetic acid, alpha-(hydroxymethyl)-, (1alpha,2beta,4beta,5alpha,7beta)-9-methyl-3-oxa-9-azatricyclo(3.3.1.02,4)non-7-yl ester, (alphaS)-, Benzeneacetic acid, alpha-(hydroxymethyl)-, 9-methyl-3-oxa-9-azatricyclo(3.3.1.02,4)non-7-yl ester, (7(S)-(1alpha,2beta,4beta,5alpha,7beta))-, OW0 |
||